However, the ACA left in place the existing prohibition on Medicare negotiating drug prices a policy originally set by the 2003 Medicare Modernization Act in part to maintain support from pharmaceutical industry stakeholders
Our mission is to provide you with a transparent, science-backed path to sustainable weight loss
That narrow majority put the committee on the opposite side of FDA staff, whose written review recommended against inclusion
For the millions of people with MASLD who currently have no approved pharmacological treatment, retatrutide represents potentially transformative therapy
Approval would greatly expand access and possibly lower cost through insurance coverage
For drug development, the GLP-1 receptor agonist structure should also be considered, since ligand orientation, peptide modifications, and half-life-extending features directly influence pharmacokinetics and receptor interactions